Evolent Health, Inc. (EVH)
| Market Cap | 362.82M |
| Revenue (ttm) | 1.88B |
| Net Income (ttm) | -557.38M |
| Shares Out | 111.64M |
| EPS (ttm) | -4.88 |
| PE Ratio | n/a |
| Forward PE | 17.97 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,185,543 |
| Open | 3.280 |
| Previous Close | 3.320 |
| Day's Range | 3.125 - 3.340 |
| 52-Week Range | 2.500 - 12.065 |
| Beta | 0.24 |
| Analysts | Strong Buy |
| Price Target | 8.36 (+157.23%) |
| Earnings Date | Feb 24, 2026 |
About EVH
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, an... [Read more]
Financial Performance
In 2025, Evolent Health's revenue was $1.88 billion, a decrease of -26.56% compared to the previous year's $2.55 billion. Losses were -$557.38 million, 432.0% more than in 2024.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for EVH stock is "Strong Buy." The 12-month stock price target is $8.36, which is an increase of 157.23% from the latest price.
News
Evolent to Participate in Upcoming Investor Conferences
WASHINGTON, Feb. 26, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced that members of it...
Evolent Health: Cheap, Levered, But Ready To Rebound
Evolent Health, Inc. is rated a Buy, with turnaround momentum and risk/reward now favoring upside after recent operational and strategic shifts. EVH's Performance Suite model now covers ~90% of revenu...
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through...
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its...
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
WASHINGTON, Jan. 2, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through ...
Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript
Evolent Health, Inc. ( EVH) UBS Global Healthcare Conference 2025 November 11, 2025 5:00 PM EST Company Participants John Johnson - Chief Financial Officer Conference Call Participants Kevin Caliendo...
Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript
Evolent Health, Inc. ( EVH) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Seth Blackley - Co-Founder, CEO & Director John Johnson - Chief Financial Officer Conference Call P...
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
WASHINGTON , Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON...
Evolent Announces Third Quarter 2025 Results
Q3 2025 financial results ahead of expectations. Announces more than $500 million in newly-contracted annualized revenue to launch in 2026.
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Company to Participate in Upcoming Conferences WASHINGTON , Oct. 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex...
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path. Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to ...
Evolent's Soft Q2 Results: Why I'm Holding Anyway
Evolent's revenue dip in Q1 was structural, not demand-driven, and Q2 shows stabilization; I expect growth to resume in the second half of 2025. New specialty contracts, incremental member growth, and...
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
WASHINGTON , Aug. 19, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced the p...
Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
WASHINGTON , Aug. 18, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that ...
Evolent Health, Inc. (EVH) Q2 2025 Earnings Call Transcript
Evolent Health, Inc. (NYSE:EVH) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants John Paul Johnson - Chief Financial Officer Seth Barrie Blackley - Co-Founder, CEO & Di...
Evolent Announces Second Quarter 2025 Results
WASHINGTON , Aug. 7, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through...
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Company to Participate in Upcoming Conferences WASHINGTON , July 14, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with comple...
Evolent announces key appointments to leadership team
Dr. David Lim joins Evolent as chief clinical officer John Way joins Evolent as CFO, Performance Suite WASHINGTON , July 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on ...
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA
Notes accelerating 2026 revenue bookings forecast Secures incremental non-dilutive financing WASHINGTON , June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving...
Evolent Health, Inc. (EVH) Q1 2025 Earnings Call Transcript
Evolent Health, Inc. (NYSE:EVH) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference ...
Evolent Announces First Quarter 2025 Results
WASHINGTON , May 8, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through ...
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors
Former CFO of CVS Health, Aetna and Coventry Health Care brings deep experience driving growth and profitability. Mr. Guertin's nomination represents continuation of Evolent's board refreshment effort...
Evolent program achieves 20% reduction in use of low-value oncology regimens
Program aims to achieve the best possible treatment outcomes — longer lives with fewer side-effects — without excess financial strain. Collegial provider engagement model brings together education, te...
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025
Company to Participate in Upcoming Conferences WASHINGTON , April 10, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with compl...